Companies

Shire’s $5.2bn bet on NPS

Name: Shire’s $5.2bn bet on NPS
Uploaded: 2015-01-12T14:19:07.168Z
Duration: 3 min 15 s
Channel: Financial Times
Description: Lex on mid-sized pharma’s growing risks

Once the prey, now the predator, Shire makes its biggest acquisition by buying the US biotechnology company NPS for $5.2bn. Lex's Oliver Ralph and Robert Armstrong discuss the growing risks mid-sized pharmaceutical groups must take.

January 12, 2015

Filmed by Rod Fitzgerald and Nicola Stansfield. Produced by Darryl Thomson.